Clinical decision support

Aktiia announced an oversubscribed $42 million Series B round, and Basil Systems secured $11.5 million in funding.

Claimed to be a world's first, the LLM-driven model has demonstrated over 90% accuracy.  

The community-based program targets to screen 260,000 women.  

Also, an AI-powered breath test for diagnosing silicosis has been developed in Sydney.

Also, Cureskin from India has launched an AI-powered hair analysis feature on its mobile application.

The hospital-focused telehealth and virtual care delivery company, which currently works with more than 70 health systems, will use the funds to scale its reach. 

The study has demonstrated the potential of predictable movement stimuli as a behavioural marker of autism spectrum disorder.

Developed using a corpus of 38 million clinical texts, the open-source model scored 86% in the Korean Medical Licensing Examination.

The EMR-linked tool has been implemented across 16 departments.

The lack of a strong set of AI-specific regulation in the U.S. allows innovation to happen quickly, but that also requires companies to be transparent and for the industry to take responsibility for its own actions, says Mika Newton, CEO of xCures.